ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SOX3
|
ENSG00000134595.6 | SOX3 |
SOX2
|
ENSG00000181449.2 | SOX2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX3 | hg19_v2_chrX_-_139587225_139587234 | -0.05 | 8.4e-01 | Click! |
SOX2 | hg19_v2_chr3_+_181429704_181429722 | 0.03 | 9.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_110959478 | 11.04 |
ENST00000543140.1 ENST00000375820.4 |
COL4A1 |
collagen, type IV, alpha 1 |
chr1_-_95391315 | 10.68 |
ENST00000545882.1 ENST00000415017.1 |
CNN3 |
calponin 3, acidic |
chr7_+_102553430 | 10.22 |
ENST00000339431.4 ENST00000249377.4 |
LRRC17 |
leucine rich repeat containing 17 |
chr5_-_16936340 | 9.91 |
ENST00000507288.1 ENST00000513610.1 |
MYO10 |
myosin X |
chr6_-_128841503 | 9.74 |
ENST00000368215.3 ENST00000532331.1 ENST00000368213.5 ENST00000368207.3 ENST00000525459.1 ENST00000368210.3 ENST00000368226.4 ENST00000368227.3 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
chr2_-_1748214 | 9.54 |
ENST00000433670.1 ENST00000425171.1 ENST00000252804.4 |
PXDN |
peroxidasin homolog (Drosophila) |
chr4_+_146403912 | 9.02 |
ENST00000507367.1 ENST00000394092.2 ENST00000515385.1 |
SMAD1 |
SMAD family member 1 |
chrX_-_38080077 | 7.74 |
ENST00000378533.3 ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX |
sushi-repeat containing protein, X-linked |
chr6_+_114178512 | 6.32 |
ENST00000368635.4 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
chr9_+_103235365 | 5.98 |
ENST00000374879.4 |
TMEFF1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr7_+_134464414 | 5.75 |
ENST00000361901.2 |
CALD1 |
caldesmon 1 |
chr2_-_175869936 | 5.37 |
ENST00000409900.3 |
CHN1 |
chimerin 1 |
chr10_+_123923105 | 5.36 |
ENST00000368999.1 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr8_-_17579726 | 5.28 |
ENST00000381861.3 |
MTUS1 |
microtubule associated tumor suppressor 1 |
chr4_-_186877502 | 4.97 |
ENST00000431902.1 ENST00000284776.7 ENST00000415274.1 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr4_-_186732048 | 4.81 |
ENST00000448662.2 ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr10_+_123923205 | 4.80 |
ENST00000369004.3 ENST00000260733.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr12_-_6233828 | 4.79 |
ENST00000572068.1 ENST00000261405.5 |
VWF |
von Willebrand factor |
chr5_-_39425222 | 4.69 |
ENST00000320816.6 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
chr1_-_225840747 | 4.64 |
ENST00000366843.2 ENST00000366844.3 |
ENAH |
enabled homolog (Drosophila) |
chr13_+_110959598 | 4.62 |
ENST00000360467.5 |
COL4A2 |
collagen, type IV, alpha 2 |
chr7_+_134464376 | 4.58 |
ENST00000454108.1 ENST00000361675.2 |
CALD1 |
caldesmon 1 |
chr5_-_39425290 | 4.57 |
ENST00000545653.1 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
chr6_-_134639180 | 4.19 |
ENST00000367858.5 |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
chr5_-_176900610 | 4.18 |
ENST00000477391.2 ENST00000393565.1 ENST00000309007.5 |
DBN1 |
drebrin 1 |
chr5_-_111091948 | 4.13 |
ENST00000447165.2 |
NREP |
neuronal regeneration related protein |
chr4_-_40859132 | 4.12 |
ENST00000543538.1 ENST00000502841.1 ENST00000504305.1 ENST00000513516.1 ENST00000510670.1 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
chr2_-_216257849 | 4.00 |
ENST00000456923.1 |
FN1 |
fibronectin 1 |
chr8_+_26435359 | 3.88 |
ENST00000311151.5 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chr10_+_123922941 | 3.83 |
ENST00000360561.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr3_+_159557637 | 3.59 |
ENST00000445224.2 |
SCHIP1 |
schwannomin interacting protein 1 |
chr16_+_3068393 | 3.54 |
ENST00000573001.1 |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
chr7_-_27219849 | 3.51 |
ENST00000396344.4 |
HOXA10 |
homeobox A10 |
chr11_+_114168085 | 3.49 |
ENST00000541754.1 |
NNMT |
nicotinamide N-methyltransferase |
chr6_-_11232891 | 3.47 |
ENST00000379433.5 ENST00000379446.5 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
chr5_-_146833485 | 3.46 |
ENST00000398514.3 |
DPYSL3 |
dihydropyrimidinase-like 3 |
chr2_-_161349909 | 3.44 |
ENST00000392753.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chrY_+_15016013 | 3.38 |
ENST00000360160.4 ENST00000454054.1 |
DDX3Y |
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr5_-_39425068 | 3.36 |
ENST00000515700.1 ENST00000339788.6 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
chr8_-_18871159 | 3.25 |
ENST00000327040.8 ENST00000440756.2 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
chr10_-_30024716 | 3.23 |
ENST00000375398.2 ENST00000375400.3 |
SVIL |
supervillin |
chr2_+_9346892 | 3.17 |
ENST00000281419.3 ENST00000315273.4 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
chr1_+_93913713 | 3.17 |
ENST00000604705.1 ENST00000370253.2 |
FNBP1L |
formin binding protein 1-like |
chr4_-_7941596 | 3.17 |
ENST00000420658.1 ENST00000358461.2 |
AFAP1 |
actin filament associated protein 1 |
chr2_-_151344172 | 3.12 |
ENST00000375734.2 ENST00000263895.4 ENST00000454202.1 |
RND3 |
Rho family GTPase 3 |
chr10_-_62704005 | 3.12 |
ENST00000337910.5 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
chr7_-_107643674 | 3.09 |
ENST00000222399.6 |
LAMB1 |
laminin, beta 1 |
chr9_+_139874683 | 3.06 |
ENST00000444903.1 |
PTGDS |
prostaglandin D2 synthase 21kDa (brain) |
chr3_-_149095652 | 3.03 |
ENST00000305366.3 |
TM4SF1 |
transmembrane 4 L six family member 1 |
chr22_-_36357671 | 3.00 |
ENST00000408983.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr11_+_86511569 | 2.99 |
ENST00000441050.1 |
PRSS23 |
protease, serine, 23 |
chr12_-_106641728 | 2.99 |
ENST00000378026.4 |
CKAP4 |
cytoskeleton-associated protein 4 |
chr12_-_15942503 | 2.97 |
ENST00000281172.5 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
chr3_-_123339418 | 2.96 |
ENST00000583087.1 |
MYLK |
myosin light chain kinase |
chrX_+_51927919 | 2.91 |
ENST00000416960.1 |
MAGED4 |
melanoma antigen family D, 4 |
chr7_-_47621736 | 2.90 |
ENST00000311160.9 |
TNS3 |
tensin 3 |
chr2_-_161350305 | 2.90 |
ENST00000348849.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr10_-_33247124 | 2.87 |
ENST00000414670.1 ENST00000302278.3 ENST00000374956.4 ENST00000488494.1 ENST00000417122.2 ENST00000474568.1 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
chr2_-_37899323 | 2.85 |
ENST00000295324.3 ENST00000457889.1 |
CDC42EP3 |
CDC42 effector protein (Rho GTPase binding) 3 |
chr3_-_123339343 | 2.85 |
ENST00000578202.1 |
MYLK |
myosin light chain kinase |
chr12_-_15942309 | 2.85 |
ENST00000544064.1 ENST00000543523.1 ENST00000536793.1 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
chr15_+_77224045 | 2.85 |
ENST00000320963.5 ENST00000394883.3 |
RCN2 |
reticulocalbin 2, EF-hand calcium binding domain |
chr11_+_20044600 | 2.80 |
ENST00000311043.8 |
NAV2 |
neuron navigator 2 |
chr1_+_100111479 | 2.79 |
ENST00000263174.4 |
PALMD |
palmdelphin |
chr18_+_3447572 | 2.78 |
ENST00000548489.2 |
TGIF1 |
TGFB-induced factor homeobox 1 |
chr3_-_114343768 | 2.77 |
ENST00000393785.2 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr15_+_63335899 | 2.73 |
ENST00000561266.1 |
TPM1 |
tropomyosin 1 (alpha) |
chr3_-_120170052 | 2.72 |
ENST00000295633.3 |
FSTL1 |
follistatin-like 1 |
chr11_+_114128522 | 2.70 |
ENST00000535401.1 |
NNMT |
nicotinamide N-methyltransferase |
chr3_-_149688655 | 2.70 |
ENST00000461930.1 ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2 |
profilin 2 |
chr14_+_85996471 | 2.70 |
ENST00000330753.4 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
chr1_-_173174681 | 2.67 |
ENST00000367718.1 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
chr18_+_3449821 | 2.61 |
ENST00000407501.2 ENST00000405385.3 ENST00000546979.1 |
TGIF1 |
TGFB-induced factor homeobox 1 |
chr13_+_76334795 | 2.57 |
ENST00000526202.1 ENST00000465261.2 |
LMO7 |
LIM domain 7 |
chr4_-_157892498 | 2.57 |
ENST00000502773.1 |
PDGFC |
platelet derived growth factor C |
chr17_-_7297519 | 2.55 |
ENST00000576362.1 ENST00000571078.1 |
TMEM256-PLSCR3 |
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr2_-_224903995 | 2.53 |
ENST00000409304.1 ENST00000454956.1 ENST00000258405.4 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr1_+_100111580 | 2.49 |
ENST00000605497.1 |
PALMD |
palmdelphin |
chr1_+_25071848 | 2.47 |
ENST00000374379.4 |
CLIC4 |
chloride intracellular channel 4 |
chr15_+_77223960 | 2.47 |
ENST00000394885.3 |
RCN2 |
reticulocalbin 2, EF-hand calcium binding domain |
chr12_-_8815215 | 2.44 |
ENST00000544889.1 ENST00000543369.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr13_+_76334567 | 2.43 |
ENST00000321797.8 |
LMO7 |
LIM domain 7 |
chr15_+_80696666 | 2.41 |
ENST00000303329.4 |
ARNT2 |
aryl-hydrocarbon receptor nuclear translocator 2 |
chr1_+_169075554 | 2.40 |
ENST00000367815.4 |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr5_+_15500280 | 2.40 |
ENST00000504595.1 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
chr11_-_89224508 | 2.39 |
ENST00000525196.1 |
NOX4 |
NADPH oxidase 4 |
chr11_+_19799327 | 2.39 |
ENST00000540292.1 |
NAV2 |
neuron navigator 2 |
chr3_+_159570722 | 2.36 |
ENST00000482804.1 |
SCHIP1 |
schwannomin interacting protein 1 |
chr11_-_89224638 | 2.31 |
ENST00000535633.1 ENST00000263317.4 |
NOX4 |
NADPH oxidase 4 |
chr5_+_135364584 | 2.29 |
ENST00000442011.2 ENST00000305126.8 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
chr17_-_7297833 | 2.28 |
ENST00000571802.1 ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3 |
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr5_+_34656331 | 2.25 |
ENST00000265109.3 |
RAI14 |
retinoic acid induced 14 |
chr2_+_102314161 | 2.23 |
ENST00000425019.1 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
chr11_+_19798964 | 2.23 |
ENST00000527559.2 |
NAV2 |
neuron navigator 2 |
chr11_-_2162468 | 2.23 |
ENST00000434045.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr5_+_34656569 | 2.23 |
ENST00000428746.2 |
RAI14 |
retinoic acid induced 14 |
chr3_-_149688502 | 2.22 |
ENST00000481767.1 ENST00000475518.1 |
PFN2 |
profilin 2 |
chr1_-_173176452 | 2.22 |
ENST00000281834.3 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
chr3_-_149688896 | 2.22 |
ENST00000239940.7 |
PFN2 |
profilin 2 |
chrX_-_51812268 | 2.22 |
ENST00000486010.1 ENST00000497164.1 ENST00000360134.6 ENST00000485287.1 ENST00000335504.5 ENST00000431659.1 |
MAGED4B |
melanoma antigen family D, 4B |
chr14_+_105941118 | 2.21 |
ENST00000550577.1 ENST00000538259.2 |
CRIP2 |
cysteine-rich protein 2 |
chr7_+_134551583 | 2.19 |
ENST00000435928.1 |
CALD1 |
caldesmon 1 |
chr10_-_70092671 | 2.18 |
ENST00000358769.2 ENST00000432941.1 ENST00000495025.2 |
PBLD |
phenazine biosynthesis-like protein domain containing |
chr8_+_79428539 | 2.17 |
ENST00000352966.5 |
PKIA |
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
chrX_+_135229600 | 2.16 |
ENST00000370690.3 |
FHL1 |
four and a half LIM domains 1 |
chr4_+_78078304 | 2.16 |
ENST00000316355.5 ENST00000354403.5 ENST00000502280.1 |
CCNG2 |
cyclin G2 |
chr12_-_8803128 | 2.15 |
ENST00000543467.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr2_+_192109911 | 2.15 |
ENST00000418908.1 ENST00000339514.4 ENST00000392318.3 |
MYO1B |
myosin IB |
chr8_+_79578282 | 2.11 |
ENST00000263849.4 |
ZC2HC1A |
zinc finger, C2HC-type containing 1A |
chrX_-_13956497 | 2.11 |
ENST00000398361.3 |
GPM6B |
glycoprotein M6B |
chr13_-_24007815 | 2.08 |
ENST00000382298.3 |
SACS |
spastic ataxia of Charlevoix-Saguenay (sacsin) |
chr1_-_95392635 | 2.07 |
ENST00000538964.1 ENST00000394202.4 ENST00000370206.4 |
CNN3 |
calponin 3, acidic |
chr13_-_33760216 | 2.06 |
ENST00000255486.4 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
chr4_+_41614909 | 2.05 |
ENST00000509454.1 ENST00000396595.3 ENST00000381753.4 |
LIMCH1 |
LIM and calponin homology domains 1 |
chr17_-_78009647 | 2.05 |
ENST00000310924.2 |
TBC1D16 |
TBC1 domain family, member 16 |
chrX_+_15518923 | 2.03 |
ENST00000348343.6 |
BMX |
BMX non-receptor tyrosine kinase |
chr10_+_123872483 | 2.03 |
ENST00000369001.1 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr2_+_192110199 | 2.02 |
ENST00000304164.4 |
MYO1B |
myosin IB |
chr5_+_102201509 | 2.02 |
ENST00000348126.2 ENST00000379787.4 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
chr9_-_130639997 | 2.01 |
ENST00000373176.1 |
AK1 |
adenylate kinase 1 |
chr12_-_8815299 | 2.01 |
ENST00000535336.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr22_+_39052632 | 2.00 |
ENST00000411557.1 ENST00000396811.2 ENST00000216029.3 ENST00000416285.1 |
CBY1 |
chibby homolog 1 (Drosophila) |
chr10_+_114710211 | 2.00 |
ENST00000349937.2 ENST00000369397.4 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr4_-_2264015 | 1.94 |
ENST00000337190.2 |
MXD4 |
MAX dimerization protein 4 |
chr14_+_85996507 | 1.93 |
ENST00000554746.1 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
chrX_+_102631844 | 1.92 |
ENST00000372634.1 ENST00000299872.7 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr20_-_43977055 | 1.90 |
ENST00000372733.3 ENST00000537976.1 |
SDC4 |
syndecan 4 |
chr2_+_33172221 | 1.89 |
ENST00000354476.3 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
chr2_+_69240302 | 1.88 |
ENST00000303714.4 |
ANTXR1 |
anthrax toxin receptor 1 |
chr10_-_91174215 | 1.87 |
ENST00000371837.1 |
LIPA |
lipase A, lysosomal acid, cholesterol esterase |
chr8_-_119964434 | 1.85 |
ENST00000297350.4 |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
chr11_-_89224299 | 1.84 |
ENST00000343727.5 ENST00000531342.1 ENST00000375979.3 |
NOX4 |
NADPH oxidase 4 |
chr5_-_111092930 | 1.82 |
ENST00000257435.7 |
NREP |
neuronal regeneration related protein |
chr11_-_6341724 | 1.82 |
ENST00000530979.1 |
PRKCDBP |
protein kinase C, delta binding protein |
chr17_-_10325261 | 1.80 |
ENST00000403437.2 |
MYH8 |
myosin, heavy chain 8, skeletal muscle, perinatal |
chr7_+_116312411 | 1.79 |
ENST00000456159.1 ENST00000397752.3 ENST00000318493.6 |
MET |
met proto-oncogene |
chr5_-_54281407 | 1.78 |
ENST00000381403.4 |
ESM1 |
endothelial cell-specific molecule 1 |
chr11_+_32112431 | 1.78 |
ENST00000054950.3 |
RCN1 |
reticulocalbin 1, EF-hand calcium binding domain |
chr8_-_48651648 | 1.78 |
ENST00000408965.3 |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
chr13_-_107187462 | 1.77 |
ENST00000245323.4 |
EFNB2 |
ephrin-B2 |
chrX_+_51928002 | 1.77 |
ENST00000375626.3 |
MAGED4 |
melanoma antigen family D, 4 |
chr9_+_116263639 | 1.77 |
ENST00000343817.5 |
RGS3 |
regulator of G-protein signaling 3 |
chr15_-_35088340 | 1.76 |
ENST00000290378.4 |
ACTC1 |
actin, alpha, cardiac muscle 1 |
chr5_+_140749803 | 1.75 |
ENST00000576222.1 |
PCDHGB3 |
protocadherin gamma subfamily B, 3 |
chr9_+_116263778 | 1.75 |
ENST00000394646.3 |
RGS3 |
regulator of G-protein signaling 3 |
chr5_-_150521192 | 1.74 |
ENST00000523714.1 ENST00000521749.1 |
ANXA6 |
annexin A6 |
chr12_+_49212514 | 1.73 |
ENST00000301050.2 ENST00000548279.1 ENST00000547230.1 |
CACNB3 |
calcium channel, voltage-dependent, beta 3 subunit |
chr9_+_36036430 | 1.72 |
ENST00000377966.3 |
RECK |
reversion-inducing-cysteine-rich protein with kazal motifs |
chrX_+_135229559 | 1.71 |
ENST00000394155.2 |
FHL1 |
four and a half LIM domains 1 |
chr5_+_140593509 | 1.71 |
ENST00000341948.4 |
PCDHB13 |
protocadherin beta 13 |
chr6_-_167040731 | 1.71 |
ENST00000265678.4 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
chr8_-_27469196 | 1.71 |
ENST00000546343.1 ENST00000560566.1 |
CLU |
clusterin |
chr2_+_69240511 | 1.69 |
ENST00000409349.3 |
ANTXR1 |
anthrax toxin receptor 1 |
chr1_-_79472365 | 1.69 |
ENST00000370742.3 |
ELTD1 |
EGF, latrophilin and seven transmembrane domain containing 1 |
chrX_+_114827818 | 1.65 |
ENST00000420625.2 |
PLS3 |
plastin 3 |
chr8_-_27468842 | 1.63 |
ENST00000523500.1 |
CLU |
clusterin |
chr8_-_27468945 | 1.63 |
ENST00000405140.3 |
CLU |
clusterin |
chr10_+_17272608 | 1.63 |
ENST00000421459.2 |
VIM |
vimentin |
chr14_+_50234827 | 1.63 |
ENST00000554589.1 ENST00000557247.1 |
KLHDC2 |
kelch domain containing 2 |
chr1_-_68698222 | 1.62 |
ENST00000370976.3 ENST00000354777.2 ENST00000262348.4 ENST00000540432.1 |
WLS |
wntless Wnt ligand secretion mediator |
chr8_-_18541603 | 1.62 |
ENST00000428502.2 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
chr11_-_89224488 | 1.61 |
ENST00000534731.1 ENST00000527626.1 |
NOX4 |
NADPH oxidase 4 |
chr3_-_57583052 | 1.60 |
ENST00000496292.1 ENST00000489843.1 |
ARF4 |
ADP-ribosylation factor 4 |
chr15_+_85923797 | 1.60 |
ENST00000559362.1 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
chr1_-_33815486 | 1.59 |
ENST00000373418.3 |
PHC2 |
polyhomeotic homolog 2 (Drosophila) |
chr3_-_139258521 | 1.58 |
ENST00000483943.2 ENST00000232219.2 ENST00000492918.1 |
RBP1 |
retinol binding protein 1, cellular |
chr10_+_180405 | 1.58 |
ENST00000439456.1 ENST00000397962.3 ENST00000309776.4 ENST00000381602.4 |
ZMYND11 |
zinc finger, MYND-type containing 11 |
chr6_-_47277634 | 1.58 |
ENST00000296861.2 |
TNFRSF21 |
tumor necrosis factor receptor superfamily, member 21 |
chr2_-_55276320 | 1.56 |
ENST00000357376.3 |
RTN4 |
reticulon 4 |
chr5_+_109025067 | 1.55 |
ENST00000261483.4 |
MAN2A1 |
mannosidase, alpha, class 2A, member 1 |
chr5_+_140797296 | 1.54 |
ENST00000398594.2 |
PCDHGB7 |
protocadherin gamma subfamily B, 7 |
chr2_-_106015491 | 1.54 |
ENST00000408995.1 ENST00000393353.3 ENST00000322142.8 |
FHL2 |
four and a half LIM domains 2 |
chr17_-_76921459 | 1.51 |
ENST00000262768.7 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
chr2_-_165424973 | 1.51 |
ENST00000543549.1 |
GRB14 |
growth factor receptor-bound protein 14 |
chr5_-_54281491 | 1.50 |
ENST00000381405.4 |
ESM1 |
endothelial cell-specific molecule 1 |
chrX_-_10645773 | 1.50 |
ENST00000453318.2 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
chr4_-_99578789 | 1.50 |
ENST00000511651.1 ENST00000505184.1 |
TSPAN5 |
tetraspanin 5 |
chr9_+_124088860 | 1.50 |
ENST00000373806.1 |
GSN |
gelsolin |
chr16_+_6069586 | 1.50 |
ENST00000547372.1 |
RBFOX1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr16_+_57673430 | 1.49 |
ENST00000540164.2 ENST00000568531.1 |
GPR56 |
G protein-coupled receptor 56 |
chr4_-_22517620 | 1.49 |
ENST00000502482.1 ENST00000334304.5 |
GPR125 |
G protein-coupled receptor 125 |
chr16_+_89989687 | 1.49 |
ENST00000315491.7 ENST00000555576.1 ENST00000554336.1 ENST00000553967.1 |
TUBB3 |
Tubulin beta-3 chain |
chr8_-_38326119 | 1.48 |
ENST00000356207.5 ENST00000326324.6 |
FGFR1 |
fibroblast growth factor receptor 1 |
chr17_-_62502022 | 1.48 |
ENST00000578804.1 |
DDX5 |
DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
chr14_+_96505659 | 1.48 |
ENST00000555004.1 |
C14orf132 |
chromosome 14 open reading frame 132 |
chr15_+_25200074 | 1.46 |
ENST00000390687.4 ENST00000584968.1 ENST00000346403.6 ENST00000554227.2 |
SNRPN |
small nuclear ribonucleoprotein polypeptide N |
chr5_+_76011868 | 1.46 |
ENST00000319211.4 |
F2R |
coagulation factor II (thrombin) receptor |
chr20_+_11898507 | 1.46 |
ENST00000378226.2 |
BTBD3 |
BTB (POZ) domain containing 3 |
chr4_+_47487285 | 1.45 |
ENST00000273859.3 ENST00000504445.1 |
ATP10D |
ATPase, class V, type 10D |
chrX_+_135251783 | 1.44 |
ENST00000394153.2 |
FHL1 |
four and a half LIM domains 1 |
chr3_-_57583130 | 1.44 |
ENST00000303436.6 |
ARF4 |
ADP-ribosylation factor 4 |
chr2_+_71295733 | 1.44 |
ENST00000443938.2 ENST00000244204.6 |
NAGK |
N-acetylglucosamine kinase |
chr1_+_93913665 | 1.43 |
ENST00000271234.7 ENST00000370256.4 ENST00000260506.8 |
FNBP1L |
formin binding protein 1-like |
chr12_+_53491220 | 1.43 |
ENST00000548547.1 ENST00000301464.3 |
IGFBP6 |
insulin-like growth factor binding protein 6 |
chr1_-_17307173 | 1.43 |
ENST00000438542.1 ENST00000375535.3 |
MFAP2 |
microfibrillar-associated protein 2 |
chr17_+_1674982 | 1.43 |
ENST00000572048.1 ENST00000573763.1 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chrX_-_134049262 | 1.43 |
ENST00000370783.3 |
MOSPD1 |
motile sperm domain containing 1 |
chr12_-_49582978 | 1.43 |
ENST00000301071.7 |
TUBA1A |
tubulin, alpha 1a |
chr6_-_31697977 | 1.42 |
ENST00000375787.2 |
DDAH2 |
dimethylarginine dimethylaminohydrolase 2 |
chr1_-_110283660 | 1.41 |
ENST00000361066.2 |
GSTM3 |
glutathione S-transferase mu 3 (brain) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 12.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
2.9 | 11.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.6 | 10.2 | GO:0048539 | bone marrow development(GO:0048539) |
1.9 | 7.4 | GO:0021564 | vagus nerve development(GO:0021564) |
1.6 | 8.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.6 | 4.9 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.5 | 4.4 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
1.5 | 5.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.2 | 3.5 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
1.1 | 9.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.0 | 4.1 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
1.0 | 7.7 | GO:0001845 | phagolysosome assembly(GO:0001845) negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.9 | 3.5 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.8 | 3.4 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.8 | 4.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.8 | 2.5 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.8 | 5.0 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.8 | 3.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.8 | 3.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.8 | 4.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.8 | 2.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.8 | 3.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.7 | 11.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.7 | 5.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 3.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.6 | 12.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.6 | 1.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 2.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.6 | 12.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 4.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.6 | 7.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 2.4 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.6 | 3.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 3.4 | GO:0030421 | defecation(GO:0030421) |
0.5 | 3.3 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.5 | 2.5 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) seminal vesicle development(GO:0061107) |
0.5 | 3.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 1.5 | GO:1900133 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) regulation of renin secretion into blood stream(GO:1900133) |
0.5 | 0.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.5 | 1.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.5 | 1.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 0.9 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.4 | 3.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.4 | 2.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.4 | 2.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 2.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.4 | 1.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 3.9 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 3.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 1.2 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.4 | 1.2 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.4 | 1.5 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.4 | 1.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.4 | 2.5 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.4 | 1.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 1.0 | GO:0032242 | regulation of nucleoside transport(GO:0032242) negative regulation of neurotrophin production(GO:0032900) |
0.3 | 3.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 2.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.3 | 2.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 1.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 1.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 0.7 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.3 | 9.9 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 9.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 1.5 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.3 | 3.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 1.5 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.3 | 2.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 5.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.9 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 3.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 1.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.3 | 1.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 1.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 3.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.3 | 9.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 0.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 0.3 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 1.3 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.3 | 0.3 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.3 | 0.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 13.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 3.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 0.7 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.2 | 1.2 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.2 | 1.0 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.2 | 2.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.2 | 1.4 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.7 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.2 | 0.9 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 2.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 1.3 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 5.5 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 3.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 1.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 5.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 1.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 4.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 2.5 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 2.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 1.1 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 1.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.7 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 0.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 1.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 0.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 0.5 | GO:1904395 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
0.2 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 1.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 2.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.5 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.2 | 1.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.3 | GO:0099543 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
0.2 | 1.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 8.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 1.0 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
0.2 | 2.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.3 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.3 | GO:0061551 | cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) |
0.2 | 1.3 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.5 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.2 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.2 | 0.6 | GO:0061428 | embryonic heart tube left/right pattern formation(GO:0060971) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.6 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.1 | 1.0 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.7 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.4 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 1.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 2.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.6 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 1.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.6 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.8 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 3.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 1.2 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 1.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 1.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.8 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 1.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 13.8 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.4 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 1.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 5.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 1.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.4 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.5 | GO:0060849 | radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.1 | 0.9 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 1.9 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.5 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.1 | 0.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 1.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.3 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 1.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 1.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 3.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 2.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.1 | 1.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 1.0 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 1.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 1.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 1.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 3.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 2.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.5 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 1.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.1 | 1.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 1.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 1.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 1.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 1.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 2.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.2 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 1.8 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.1 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
0.1 | 0.1 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.1 | 1.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.5 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.1 | 1.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 2.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:2000583 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 1.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.4 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 1.2 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 2.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 1.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.9 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 1.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.0 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 1.1 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 2.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 1.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 1.1 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.0 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.3 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 1.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 1.9 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.0 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.0 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 4.9 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 1.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 1.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:1902961 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.0 | 0.9 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.1 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.0 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.7 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 9.4 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.3 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.4 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.0 | 0.1 | GO:0008105 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) asymmetric protein localization(GO:0008105) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 1.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.2 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.0 | 0.1 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0010962 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
0.0 | 0.3 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
0.0 | 0.1 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.3 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 1.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 1.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 10.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.3 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.0 | 1.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.0 | 0.2 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0043305 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.0 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.3 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.0 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.0 | 0.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.6 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.3 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.0 | 0.4 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.0 | 0.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.3 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.2 | GO:0061621 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 1.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 1.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 9.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 15.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 18.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 10.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 4.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 12.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 3.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 36.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 6.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 11.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 5.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 4.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 6.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 6.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 12.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 3.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 5.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 5.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 4.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 5.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 2.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 11.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 2.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 5.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 12.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 10.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 6.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 23.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 12.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 3.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 7.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 1.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 15.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 3.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 10.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 6.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 5.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 9.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 4.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 3.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 3.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 3.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 2.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 8.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 6.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 7.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 1.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 3.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 9.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.5 | 6.2 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
1.4 | 11.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
1.3 | 3.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.2 | 10.9 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
1.2 | 5.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 3.3 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.8 | 3.4 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.8 | 4.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.8 | 2.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.8 | 7.8 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.8 | 3.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.6 | 9.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.6 | 3.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.6 | 4.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.5 | 11.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 13.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.5 | 12.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 8.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 1.3 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.4 | 0.4 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.4 | 2.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 10.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 7.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 1.1 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.4 | 5.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.3 | 1.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 8.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 3.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.5 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.3 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 1.8 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.3 | 1.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.3 | 5.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 2.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 1.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 4.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.5 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.2 | 1.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 3.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 4.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 4.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.6 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 4.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 1.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 13.7 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 16.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 2.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 2.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.4 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0070697 | activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.1 | 1.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 2.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.6 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 2.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 1.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.8 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.5 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 1.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 2.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 6.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 7.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.6 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 2.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 1.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 1.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 4.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 8.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.5 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 1.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 5.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.3 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.1 | 1.9 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 2.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 5.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 0.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 15.3 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 2.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 2.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.4 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.1 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 1.0 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 3.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 2.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 12.8 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.5 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.8 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 6.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 1.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 2.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.1 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 7.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 2.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.9 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.2 | GO:0004530 | ribonuclease III activity(GO:0004525) deoxyribonuclease I activity(GO:0004530) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 1.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 11.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.0 | 0.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 2.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.2 | GO:0070915 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.6 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 1.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 3.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.9 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 1.3 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 1.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 2.8 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.0 | 0.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.0 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 15.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
1.6 | 14.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.4 | 4.2 | GO:0034680 | integrin alpha1-beta1 complex(GO:0034665) integrin alpha3-beta1 complex(GO:0034667) integrin alpha8-beta1 complex(GO:0034678) integrin alpha10-beta1 complex(GO:0034680) |
1.0 | 3.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.9 | 14.0 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 8.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 12.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.6 | 12.7 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.5 | 3.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.5 | 1.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 8.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 3.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 5.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 10.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 2.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 5.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.4 | 6.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.4 | 1.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 1.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 1.8 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.3 | 0.7 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.3 | 5.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 1.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 2.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 3.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 3.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 0.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 4.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 4.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 1.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 1.0 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.2 | 0.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 2.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 2.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.2 | 2.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 3.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.1 | GO:0002177 | manchette(GO:0002177) |
0.2 | 4.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.8 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 0.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.4 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 4.3 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 1.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 2.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 1.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 2.8 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.8 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 10.7 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 23.7 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 4.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 14.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 6.8 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.8 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.6 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 12.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 8.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 6.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.7 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 3.5 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 4.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.7 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 3.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 31.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.1 | 0.7 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 1.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 17.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 13.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 3.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 1.7 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 1.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.6 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 2.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 1.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.5 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.8 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 1.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 4.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 2.8 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 1.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.0 | 0.1 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.7 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.0 | 1.1 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0005770 | late endosome(GO:0005770) |